Kayıkçıoğlu, E. and Onder, A.H. 2022. The Pan-Immune-Inflammation-Value Predicts the Survival of Patients with Estrogen Receptor-Positive,Human Epidermal Growth Factor Receptor 2 (HER2)—Negative Metastatic Breast Cancer Breast Cancer Treated with CDK4/6 inhibitors: Pan-Immune-Inflammation-Value in Metastatic Breast Cancer Breast Cancer Treated with CDK4/6 inhibitors. Chronicles of Precision Medical Researchers. 3, 3 (Oct. 2022). DOI:https://doi.org/10.5281/zenodo.7195780.